Half of those on Parkinson's drugs may develop impulse control problems

June 20, 2018, American Academy of Neurology
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

Over time, half of the people taking certain drugs for Parkinson's disease may develop impulse control disorders such as compulsive gambling, shopping or eating, according to a study published in the June 20, 2018, online issue of Neurology.

In Parkinson's, a vital chemical in the brain called dopamine that regulates movement is gradually reduced. Parkinson's is treated with levodopa, which converts to dopamine in the brain, or with dopamine agonists, which work by activating dopamine receptors.

"Our study suggests that impulse control disorders are even more common than we thought in people who take dopamine agonists," said study author Jean-Christophe Corvol, MD, of the ICM Brain and Spine Institute—Pitié-Salpêtrière Hospital, Assistance Publique—Hôpitaux de Paris, Sorbonne University in Paris, France. "These disorders can lead to serious financial, legal and social and psychological problems."

The study involved 411 people who had been diagnosed with Parkinson's disease for five years or less who were followed for an average of about three years. The participants were asked in interviews about impulse control disorders such as compulsive shopping, eating, gambling or sexual behaviors.

About 87 percent of the participants had taken a dopamine agonist at least once. At the beginning of the study, 20 percent of the participants had an impulse control disorder, with 11 percent having compulsive or binge eating problems, 9 percent compulsive sexual behaviors, 5 percent compulsive shopping and 4 percent compulsive gambling. Six percent of people had more than one impulse control disorder.

Of the 306 people who did not have impulse control disorders at the start of the study, 94 people developed a disorder during the study, for an overall five-year cumulative incidence of 46 percent. For people who had never taken dopamine agonists the five-year incidence was 12 percent, compared to 52 percent for those who had ever used the drugs. The average annual incidence was 26 per 1,000 person-years in people who never took the drugs, compared to 119 per 1,000 person-years in those who had taken the drugs.

"These disorders can be challenging for neurologists to discover," said Laura S. Boylan, MD, of New York University in New York, NY, and a Fellow of the American Academy of Neurology, who wrote an editorial accompanying the article. "People might be ashamed to tell their doctor about their problems, they may think these issues are not related to their Parkinson's disease, or they may not even consider the disorders a problem. Plus, as doctors' time for meeting with each patient gets shorter and shorter, bringing up sensitive issues gets harder and harder."

The researchers also found that with higher doses of the drugs and taking them for longer periods of time, people were more likely to develop impulse control disorders. The drugs pramipexole and ropinirole were associated with the highest risk of developing the disorders.

A total of 30 people with impulse disorders who stopped taking dopamine agonists were followed during the study. The disorders stopped over time, with half of the people no longer having issues after a year.

One limitation of the study was that because the participants were relatively young, with an average age of 62, and younger people are more likely to be given agonists and to have , it's possible that the occurrence rate of these could be overestimated.

Explore further: Study: Parkinson's disease itself does not increase risk of gambling, shopping addiction

Related Stories

Study: Parkinson's disease itself does not increase risk of gambling, shopping addiction

January 7, 2013
Parkinson's disease itself does not increase the risk of impulse control problems such as compulsive gambling and shopping that have been seen in people taking certain drugs for Parkinson's disease, according to new research ...

Impulsivity in Parkinson's disease

October 30, 2017
Dopamine medications are effective in treating the motor symptoms of Parkinson's disease (PD), but dopamine agonists can trigger impulsive-compulsive behaviors (ICBs), such as compulsive gambling, eating or shopping, in a ...

Parkinson's disease meds increase risk of compulsive gambling, shopping, binge eating

April 5, 2016
Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, report neurologists ...

Gambling, hypersexuality, compulsive shopping associated with dopamine agonist drugs

October 20, 2014
During a 10-year period, there were 1,580 adverse drug events reported in the United States and 21 other countries that indicated impulse control disorders in patients, including 628 cases of pathological gambling, 465 cases ...

Recommended for you

Genomic dark matter activity connects Parkinson's and psychiatric diseases

September 20, 2018
Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel. New genetic evidence has revealed that these specialized cells ...

Gene therapy shown to remove core component of Parkinson's disease

September 14, 2018
An international team led by Rush researcher Jeffrey Kordower, Ph.D., has moved a step closer to developing a treatment to clear brain cells of a protein that is an integral cause of Parkinson's disease. The team published ...

ADHD may increase risk of Parkinson's disease and similar disorders

September 12, 2018
While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder (ADHD), the long-term health effects of having ADHD and of common ADHD medications remains understudied. ...

New high-throughput screening study may open up for future Parkinson's disease therapy

September 11, 2018
Parkinson's disease (PD) is the most common movement disorder in the world. PD patients suffer from shaking, rigidity, slowness of movement and difficulty with walking. It is a neurodegenerative disease caused by the loss ...

Marmosets serve as an effective model for non-motor symptoms of Parkinson's disease

September 5, 2018
Small, New World monkeys called marmosets can mimic the sleep disturbances, changes in circadian rhythm, and cognitive impairment people with Parkinson's disease develop, according to a new study by scientists at Texas Biomedical ...

Novel brain network linked to chronic pain in Parkinson's disease

August 28, 2018
Scientists have revealed a novel brain network that links pain in Parkinson's disease (PD) to a specific region of the brain, according to a report in the journal eLife.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.